283 related articles for article (PubMed ID: 31437616)
1. Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder.
Turna J; Grosman Kaplan K; Patterson B; Bercik P; Anglin R; Soreni N; Van Ameringen M
J Psychiatr Res; 2019 Nov; 118():1-6. PubMed ID: 31437616
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of irritable bowel syndrome in obsessive-compulsive disorder.
Masand PS; Keuthen NJ; Gupta S; Virk S; Yu-Siao B; Kaplan D
CNS Spectr; 2006 Jan; 11(1):21-5. PubMed ID: 16400252
[TBL] [Abstract][Full Text] [Related]
3. The association between obsessive compulsive disorder and obsessive compulsive personality disorder: prevalence and clinical presentation.
Gordon OM; Salkovskis PM; Oldfield VB; Carter N
Br J Clin Psychol; 2013 Sep; 52(3):300-15. PubMed ID: 23865406
[TBL] [Abstract][Full Text] [Related]
4. Body dysmorphic disorder in patients with obsessive-compulsive disorder: prevalence and clinical correlates.
Conceição Costa DL; Chagas Assunção M; Arzeno Ferrão Y; Archetti Conrado L; Hajaj Gonzalez C; Franklin Fontenelle L; Fossaluza V; Constantino Miguel E; Rodrigues Torres A; Gedanke Shavitt R
Depress Anxiety; 2012 Nov; 29(11):966-75. PubMed ID: 22815241
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect.
Overbeek T; Schruers K; Vermetten E; Griez E
J Clin Psychiatry; 2002 Dec; 63(12):1106-12. PubMed ID: 12523869
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of irritable bowel syndrome and upper gastrointestinal symptoms in patients with chronic renal failure.
Kahvecioglu S; Akdag I; Kiyici M; Gullulu M; Yavuz M; Ersoy A; Dilek K; Yurtkuran M
J Nephrol; 2005; 18(1):61-6. PubMed ID: 15772924
[TBL] [Abstract][Full Text] [Related]
7. Bipolar disorder comorbidity in patients with obsessive-compulsive disorder: Prevalence and predictors.
Domingues-Castro MS; Torresan RC; Shavitt RG; Fontenelle LF; Ferrão YA; Rosário MC; Torres AR
J Affect Disord; 2019 Sep; 256():324-330. PubMed ID: 31201983
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and impact of irritable bowel syndrome in people with epilepsy.
Camara-Lemarroy CR; Escobedo-Zúñiga N; Ortiz-Zacarias D; Peña-Avendaño J; Villarreal-Garza E; Díaz-Torres MA
Epilepsy Behav; 2016 Oct; 63():29-33. PubMed ID: 27552483
[TBL] [Abstract][Full Text] [Related]
9. A comparison of symptom dimensions for obsessive compulsive disorder and obsessive compulsive-related disorders.
Say Öcal D; Özdel K; Şafak Y; Kekilli Karnaz Y; Kısa C
PLoS One; 2019; 14(7):e0218955. PubMed ID: 31276509
[TBL] [Abstract][Full Text] [Related]
10. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
Hod K; Ringel-Kulka T; Martin CF; Maharshak N; Ringel Y
J Clin Gastroenterol; 2016 Mar; 50(3):227-32. PubMed ID: 25930973
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of pure obsessive-compulsive disorder.
Torres AR; Shavitt RG; Torresan RC; Ferrão YA; Miguel EC; Fontenelle LF
Compr Psychiatry; 2013 Oct; 54(7):1042-52. PubMed ID: 23746710
[TBL] [Abstract][Full Text] [Related]
12. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of gastrointestinal symptoms, depressive symptoms and trait anxiety in young adults.
Söderquist F; Syk M; Just D; Kurbalija Novicic Z; Rasmusson AJ; Hellström PM; Ramklint M; Cunningham JL
BMC Psychiatry; 2020 Nov; 20(1):535. PubMed ID: 33176747
[TBL] [Abstract][Full Text] [Related]
14. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
[TBL] [Abstract][Full Text] [Related]
15. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.
Vu J; Kushnir V; Cassell B; Gyawali CP; Sayuk GS
Neurogastroenterol Motil; 2014 Sep; 26(9):1323-32. PubMed ID: 25070610
[TBL] [Abstract][Full Text] [Related]
16. Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
Van Oudenhove L; Törnblom H; Störsrud S; Tack J; Simrén M
Gastroenterology; 2016 Apr; 150(4):866-74. PubMed ID: 26602216
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, comorbidity, quality of life and use of services of obsessive-compulsive disorder and subthreshold obsessive-compulsive symptoms in the general adult population of Greece.
Skapinakis P; Politis S; Karampas A; Petrikis P; Mavreas V
Int J Psychiatry Clin Pract; 2019 Sep; 23(3):215-224. PubMed ID: 30987479
[No Abstract] [Full Text] [Related]
18. Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: The clinic-based prevalence rate, symptoms nature and clinical correlates.
Jeon S; Baek JH; Yang SY; Choi Y; Ahn SW; Ha K; Hong KS
J Affect Disord; 2018 Jan; 225():227-233. PubMed ID: 28841485
[TBL] [Abstract][Full Text] [Related]
19. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
[TBL] [Abstract][Full Text] [Related]
20. Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency.
Pinto-Sanchez MI; Ford AC; Avila CA; Verdu EF; Collins SM; Morgan D; Moayyedi P; Bercik P
Am J Gastroenterol; 2015 Jul; 110(7):1038-48. PubMed ID: 25964226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
